The FilmArray System from BioFire, also known as the BioFire FilmArray, is revolutionizing syndromic infectious disease diagnostics. This advanced system offers a simple, fast, and comprehensive testing solution that delivers accurate results in approximately one hour. By providing the right test the first time, the FilmArray System has the potential to greatly impact all areas of patient care.
At the core of the FilmArray System is the FDA-cleared multiplex PCR technology, which seamlessly integrates sample preparation, amplification, detection, and analysis. With just a few minutes of hands-on time, healthcare professionals can obtain results in as little as an hour. This swift turnaround time not only saves valuable time but also contributes to better patient care.
The FilmArray System currently offers six FDA-cleared panels, each designed to address specific healthcare challenges. These panels include the Respiratory Panel, Blood Culture Identification Panel, Gastrointestinal Panel, Pneumonia Panel, Meningitis/Encephalitis Panel, and Joint Infection Panel. Collectively, these panels test for over a hundred pathogens, making the FilmArray the fastest and most comprehensive diagnostic solution available.
Blood Culture ID
Meningitis / Encephalitis
It is designed to be used with comprehensive panels that each offer testing for sets of pathogens associated with some of today's MOST pressing healthcare challenges.
The BioFire BCID2 Panel is a groundbreaking test that targets 43 different pathogens associated with bloodstream infections. It can detect gram-negative bacteria, gram-positive bacteria, yeast, and even 10 antimicrobial resistance genes, all with a single test. Results are available within an hour from a positive blood culture, enabling timely and effective treatment decisions.
The FDA-cleared BioFire GI Panel tests 22 of the most common pathogens linked to gastroenteritis. This panel simplifies testing by requiring only one patient sample and one easy-to-use reagent. Within approximately one hour, healthcare professionals can obtain results that aid in diagnosing gastrointestinal infections accurately.
The BIOFIRE FILMARRAY Pneumonia Plus Panel is an incredibly comprehensive diagnostic tool. It simultaneously tests for 27 of the most common pathogens associated with lower respiratory tract infections (LRTIs) and identifies seven genetic markers of antibiotic resistance. By swiftly providing this critical information, the panel assists clinicians in making informed treatment decisions for pneumonia cases.
The BioFire ME Panel is an FDA-cleared syndromic test designed to detect 14 of the most prevalent bacterial, viral, and fungal causes of central nervous system infections. With just a small sample of cerebrospinal fluid (CSF) and about an hour of testing time, accurate results can be obtained promptly. This enables healthcare professionals to initiate appropriate treatments swiftly, potentially saving lives.
The FDA De Novo authorized BioFire RP2.1 Panel is a frontline test that aids clinicians in rapidly diagnosing respiratory infections. This panel can detect a wide range of pathogens, including COVID-19, influenza, RSV, and numerous others. By quickly identifying the causative agent, healthcare providers can implement appropriate infection control measures and treatment plans.
The BioFire JI Panel offers comprehensive testing for Gram-positive & Gram-negative bacteria, yeast, and antimicrobial resistance genes commonly associated with joint infections. With just one syndromic test & a small sample of synovial fluid, healthcare experts can obtain results for 39 clinically relevant targets in about an hour. This rapid diagnosis facilitates prompt treatment decisions and better patient outcomes.
|Meningitis Encephalitis Panel||14 Targets|
|6 Bacteria||7 Viruses||1 Fungi|
|Respiratory Panel||23 Targets|
|4 Bacteria||19 Viruses|
|Gastrointestinal Panel||22 Targets|
|13 Bacteria||5 Viruses||4 Parasites|
|Pneumonia Panel||34 Targets|
|18 Bacteria||9 Viruses||7 Antibiotic Resistance Markers|
|Blood Culture Identification Panel||43 Targets|
|24 Bacteria||9 Yeast||10 Antibiotic Resistance Markers|
|Joint Infection Panel||39 Targets|
|28 Bacteria||1 Yeast||10 Antibiotic Resistance Markers|
In conclusion, the FilmArray System from BioFire, with its fast and comprehensive testing panels, is revolutionizing infectious disease diagnostics. By delivering accurate results in about an hour, it significantly impacts patient care and enables healthcare professionals to make timely and informed treatment decisions. The FilmArray System is a game-changer in the field of syndromic infectious disease diagnostics.